TherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a research note issued to investors on Tuesday morning. The brokerage issued a hold rating on the stock.

TherapeuticsMD Stock Up 12.1 %

Shares of TherapeuticsMD stock opened at $1.39 on Tuesday. The firm’s fifty day simple moving average is $0.95 and its 200-day simple moving average is $1.15. TherapeuticsMD has a 12 month low of $0.70 and a 12 month high of $2.44.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.